Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06530615 · ClinicalTrials.gov registry record

Investigation of MP Pollution in the Human Respiratory System and Its Relationship to Lung Cancer

A clinical trial of Lung Cancer, sponsored by H. Lee Moffitt Cancer Center and Research Institute.

Active
Registry status
119
Enrollment target
1
Study location

NCT06530615 is a study of Lung Cancer that is active but no longer recruiting, run by H. Lee Moffitt Cancer Center and Research Institute. The registered enrollment target is 119 participants, below the 936-participant average among 409 other Lung Cancer trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06530615, a study of Lung Cancer, is active but no longer recruiting, sponsored by H. Lee Moffitt Cancer Center and Research Institute.

ACTIVE NOT RECRUITING
Registry status
119 participants
Enrollment target
1
Study location

Study Summary

This project will study and characterize Microplastic (MP) burden in the lungs of patients undergoing Bronchoalveolar Levage (BAL) in thoracic clinics at Moffitt.

Conditions Studied

Interventions

  • PROCEDURE Bronchoalveolar Lavage (BAL) during Bronchoscopy

Study Locations (1)

Florida

  • Moffitt Cancer Center - Tampa

Trial Details

FieldValue
Enrollment Target 119 participants
Start Date 2024-02-05
Est. Completion 2026-09-18

What the Registry Record Tells You About NCT06530615

The ClinicalTrials.gov registry entry for NCT06530615 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 119 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 936-participant average among 409 other Lung Cancer trials with a reported enrollment target (87% lower). The listed sponsor is H. Lee Moffitt Cancer Center and Research Institute, which has 502 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Lung Cancer appearing as the primary indexed condition, and to 1 intervention - of which Bronchoalveolar Lavage (BAL) during Bronchoscopy is the first listed.

NCT06530615 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT06530615 about?

NCT06530615 is a clinical study titled "Investigation of MP Pollution in the Human Respiratory System and Its Relationship to Lung Cancer". This project will study and characterize Microplastic (MP) burden in the lungs of patients undergoing Bronchoalveolar Levage (BAL) in thoracic clinics at Moffitt.

What is the current status of trial NCT06530615?

This trial is currently active not recruiting. The enrollment target is 119 participants. The study started on 2024-02-05. Estimated completion is 2026-09-18.

What conditions does trial NCT06530615 study?

This clinical trial studies the following conditions: Lung Cancer.

What interventions are being tested in trial NCT06530615?

The interventions under investigation include: Bronchoalveolar Lavage (BAL) during Bronchoscopy (PROCEDURE).

Who is sponsoring clinical trial NCT06530615?

This trial is sponsored by H. Lee Moffitt Cancer Center and Research Institute, which has 502 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06530615 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Lung Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.